Lausanne, Switzerland

Olivier Michielin

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Olivier Michielin: Pioneering Innovations for a Better Future

Introduction:

Inventor Olivier Michielin, based in Lausanne, CH, is a true pioneer in the field of technology, driven by a passion for innovation and a commitment to creating a better future through his inventive spirit.

Latest Patents:

1. Multispecific antigens binding fragments and multispecific antibodies: Olivier Michielin's invention involves multispecific antibody constructs comprising Fab fragments with mutations preventing heavy chain/light chain mispairing.

2. Kinase mutants and uses thereof: His innovations in designing kinase mutants aim to reprogram the sensitivity of a target kinase to specific inhibitors for the prevention and treatment of diseases, particularly cancer.

Career Highlights:

Olivier Michielin has a total of 4 patents to his name, showcasing his expertise in groundbreaking technologies and solutions for complex medical challenges. His dedication to pushing boundaries in the field of biotechnology is evident in his patent portfolio.

Collaborations:

Throughout his career, Olivier Michielin has collaborated with esteemed professionals such as Vincent Zoete and Jean Kadouche. Together, they have contributed to cutting-edge research and development in institutions like the Centre National De La Recherche Scientifique and the Azienda Socio Sanitaria Territoriale Papa Giovanni Xxiii.

Conclusion:

Olivier Michielin's relentless drive for innovation and his remarkable contributions to the field of biotechnology make him a standout inventor whose work continues to inspire others to strive for excellence and think outside the box in their endeavors, shaping a brighter future through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…